ArticleOncotarget2016

Tumor-selective replication herpes simplex virus-based technology significantly improves clinical detection and prognostication of viable circulating tumor cells.

Wen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.